Casdin Capital as of Sept. 30, 2019
Portfolio Holdings for Casdin Capital
Casdin Capital holds 26 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spark Therapeutics | 11.2 | $84M | 863k | 96.98 | |
| Invitae (NVTAQ) | 11.2 | $84M | 1.0M | 80.53 | |
| Blueprint Medicines (BPMC) | 9.3 | $69M | 940k | 73.47 | |
| Sarepta Therapeutics (SRPT) | 8.9 | $66M | 880k | 75.32 | |
| Myokardia | 7.8 | $58M | 1.1M | 52.15 | |
| Bluebird Bio (BLUE) | 7.5 | $56M | 613k | 91.82 | |
| Sage Therapeutics (SAGE) | 7.5 | $56M | 400k | 140.29 | |
| Alnylam Pharmaceuticals (ALNY) | 6.5 | $48M | 600k | 80.42 | |
| Agios Pharmaceuticals (AGIO) | 4.1 | $30M | 935k | 32.40 | |
| Audentes Therapeutics | 3.2 | $24M | 860k | 28.09 | |
| Caredx (CDNA) | 3.0 | $23M | 1.0M | 22.61 | |
| Voyager Therapeutics (VYGR) | 2.6 | $19M | 1.1M | 17.21 | |
| Illumina (ILMN) | 2.5 | $18M | 60k | 304.22 | |
| Homology Medicines | 2.0 | $15M | 820k | 18.10 | |
| Global Blood Therapeutics In | 1.9 | $15M | 300k | 48.52 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.8 | $13M | 463k | 29.02 | |
| Alector (ALEC) | 1.6 | $12M | 811k | 14.42 | |
| Denali Therapeutics (DNLI) | 1.3 | $10M | 650k | 15.32 | |
| Constellation Pharmceticls I | 1.3 | $9.8M | 1.5M | 6.46 | |
| Editas Medicine (EDIT) | 1.3 | $9.4M | 415k | 22.74 | |
| Twist Bioscience Corp (TWST) | 1.0 | $7.2M | 300k | 23.88 | |
| Fulcrum Therapeutics (FULC) | 0.7 | $5.3M | 844k | 6.24 | |
| Orchard Therapeutics Plc ads | 0.5 | $3.7M | 310k | 11.88 | |
| Deciphera Pharmaceuticals | 0.5 | $3.4M | 100k | 33.94 | |
| Turning Point Therapeutics I | 0.4 | $2.8M | 75k | 37.60 | |
| Stoke Therapeutics (STOK) | 0.4 | $2.8M | 130k | 21.49 |
